Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.
Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.

How to predict heart failure among patients with diabetes, prediabetes

Researchers were able to predict, with considerable accuracy, each patient's 5- and 10-year risk of heart failure.

American Heart Association on the COVID-19 vaccine: ‘We urge everyone to get vaccinated’

“Some people have expressed concerns about taking the vaccine,” the AHA wrote. “However, after review by science and medical experts, the association is confident the benefits of vaccination far exceed the very small, rare risks."

Beta-blockers make little difference for heart attack patients without heart failure or LVSD

The researchers, sharing their work in the American Journal of Cardiology, suggested multiple reasons why this may be the case.

Cardiologist discusses COVID-19, myocarditis among professional athletes and more

Matthew W. Martinez, MD, a cardiologist out of New Jersey, has years of experience working with athletes.

CKD patients on dialysis face worse TAVR outcomes, including a higher risk of in-hospital mortality

The authors examined data from more than 42,000 patients who received care from 2012 to 2017.

A real update on artificial sweeteners: Saccharin does not lead to diabetes in healthy adults

Researchers explained that their findings were different from previous studies because they took a wide variety of factors, including underlying health conditions, into account.

HHS goes live with online locator of COVID-countering therapeutic drugs

The agency has posted an interactive map showing the locations of drug distributors that have recently received shipments of two monoclonal antibody medications good for treating COVID-19.

Dr. Makary to U.S. hospital leadership: ‘Let’s stop arguing and be pragmatic’ about COVID immunization

When it comes to administering COVID-19 vaccinations to the people most in need of immunization, hospitals and health systems across the U.S. are botching the operation.

Clinical

Early pregnancy blood pressure patterns tied to hypertension risk years later

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology

Key takeaways from ACC.25: Advances in cardiovascular science

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure